Akshay Vaishnaw, EVP, R&D, CMO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 8,750 shares at $128.10 ($1.1M) on 2015-06-16, disclosed to the SEC on 2015-06-18.
Scheduled sale ($1.1M) by EVP, R&D, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $128.10 | 3,933 | $504K | 44.7% |
| 2 | $128.79 | 2,667 | $343K | 30.5% |
| 3 | $130.06 | 1,800 | $234K | 20.8% |
| 4 | $131.00 | 350 | $46K | 4.1% |
| Total | $128.83 avg | 8,750 | $1.1M | 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |